Pain Management Musculoskeletal Pain Data Focussed Commentary

To visit another floor: Press the lift button, use the HTML version, or go to the reception
.

Data focussed Commentary

Knowledge Laboratory

- Case Studies

- Quizzes

Library

Patient Decision Aids

Workshops

- <60 minute eLearning event

- Key slides

Information Mastery 1 - Introduction
Information Mastery 2 - Skills
MeReC Extra No.30
CV Disease - Background
CV Disease - Risk Assessment
Dyspepsia
Pain Overview
Rheumatoid Arthritis
NPCi blog - Pain

NICE CG 59 - Osteoarthritis
NICE TA27: Cox2 Inhibitors
CKS(PRODIGY) - Osteoarthritis
CKS(PRODIGY) - NSAIDs
CKS(PRODIGY) - Gout

Please help us to improve this site by filling in our feedback form

Pain Management

Musculoskeletal Pain -

Data Focussed Commentary

Musculoskeletal Pain

Musculoskeletal Pain Data Focussed Commentary

We have produced data-focussed commentaries to highlight areas where there appear to be differences between the evidence-base, as described elsewhere on this floor, and current clinical practice. These resources can be read on the screen by clicking the 'flash' version, or by downloading and printing the 'PDF' version.

This commentary covers a summary of the current evidence base concerning the risks of NSAIDS as described in MeReC Extra 30 and looks at the prescribing trends before and after this was published.

Flash

Click here to view the Musculoskeletal Pain Data Focussed Commentary online

PDF

Download a copy of the Musculoskeletal Pain Data Focussed Commentary

Data focussed commentaries are written in the context of careful consideration of the available evidence. There are limits to the interpretation of data and assuming it is a true reflection of clinical practice. Nevertheless, we regard the issues represented within data focussed commentaries as being legitimate issues for debate.

Terms & Conditions